Escalating drug prices have been making the news in recent months. In particular, the exorbitant price tags of two brand-name drugs used to treat Hepatitis C — Solvaldi and Harvoni — have ignited intense controversy. I talked with Leigh Purvis, director of health services research, AARP Public Policy Institute, and coauthor of AARP’s Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2013 about the trend in rising drug prices and what it means for consumers.
Boomers make up the majority of hepatitis C infections in the United States -- though many don't know they're harboring it. That's why the Centers for Disease Control and Prevention is officially recommending all boomers get screened for the liver-destroying virus.
It sounds like reasonable advice: The government is urging all baby boomers to get tested for the hepatitis C virus, which people often don't realize they have and which can damage or destroy the liver.
Hepatitis C is one of the more dastardly boogiemen in the club of chronic illnesses. In short, it is a blood-borne virus that can cause a variety of complications, such as liver damage. The Centers for Disease control report that around 3.2 million Americans are infected and is most prevalent in people born between the years 1945 and 1965.
Search AARP Blogs